Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles

References

• Gerotziafas GT, Galea V, Mbemba E, Kartechi A, Sassi M, Baccouche H, et al.. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. Thromb Res. 2011; 129: 779–86. 10.3402/jev.v2i0.19728.
   Google Scholar
• Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, et al.. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res. 2010; 125: 511–2. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer. 2010; 102(Suppl 1): S2–9. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008; 111: 4902–7. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circulation Res. 2011;108: 1284–97. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al.. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009; 15: 6830–40. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009; 27: 4834–8. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010; 8: 2596–607. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res. 2010; 125(Suppl 1): S46–S8. 10.3402/jev.v2i0.19728.
   Google Scholar
• Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res. 2010; 125(Suppl 2): S89–91. 10.3402/jev.v2i0.19728.
   Google Scholar
• Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, et al.. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost. 2008; 6: 1517–24. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009; 108: 1447–52. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Dargaud Y, Negrier C. Thrombin generation testing in haemophilia comprehensive care centres. Haemophilia. 2010; 16: 223–30. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost. 2010; 36: 865–75. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Robert S, Ghiotto J, Pirotte B, David JL, Masereel B, Pochet L, et al.. Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?. Pharmacol Res. 2009; 59: 160–6. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Serda RE, Godin B, Blanco E, Chiappini C, Ferrari M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta. 2011; 1810: 317–29. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost. 2007; 5: 520–7. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, et al.. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002; 32: 249–53. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Wang JG, Manly D, Kirchhofer D, Pawlinski R, Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost. 2009; 7: 1092–8. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Gessler F, Voss V, Dutzmann S, Seifert V, Gerlach R, Kogel D. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience. 2010; 165: 1312–22. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Peng L, Jiang H, Bradley C. Annexin V for flow cytometric detection of phosphatidylserine expression on lymphoma cells undergoing apoptosis [in Chinese]. J West China Univ Med Sci. 2001; 32: 620–4, 620.
   Google Scholar
• Conover WJ. Practical nonparametric statistics.3rd edition. John Wiley. New York, 1999
   Google Scholar
• Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, et al.. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009; 27: 4919–26. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012; 10: 919–30. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Brisson AR, Tan S, Arraud N, Gounou C. Plasmatic microvesicles: their size, morphology, phenotype revealed by cryo-electron microscopy and specific gold labeling. Int Soc Extracellular Vesicles. 2013.
   Google Scholar
• Lacroix R, Robert S, Poncelet P, Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost. 2010; 36: 807–18. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Xiong G, Aras O, Shet A, Key NS, Arriaga EA. Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection. Analyst. 2003; 128: 581–8. 10.3402/jev.v2i0.19728.
   Google Scholar
• Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al.. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011; 5: 7155–67. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Buzhynskyy N, Golczak M, Lai-Kee-Him J, Lambert O, Tessier B, Gounou C, et al.. Annexin-A6 presents two modes of association with phospholipid membranes. A combined QCM-D, AFM and cryo-TEM study. J Struct Biol. 2009; 168: 107–16. 10.3402/jev.v2i0.19728.
   Google Scholar
• Berny-Lang MA, Aslan JE, Tormoen GW, Patel IA, Bock PE, Gruber A, et al.. Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys Biol. 2011; 8: 015014. 10.3402/jev.v2i0.19728.
   Google Scholar
• Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood. 2005; 105: 2764–70. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar
• Butenas S, Parhami-Seren B, Mann KG. The influence of von Willebrand factor on factor VIII activity measurements. J Thromb Haemost. 2009; 7: 132–7. 10.3402/jev.v2i0.19728.
   Google Scholar
• Kocaturk B, Versteeg HH. Tissue factor isoforms in cancer and coagulation: may the best isoform win. Thromb Res. 2012; 129(Suppl 1): S69–75. 10.3402/jev.v2i0.19728.
   Google Scholar
• Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, et al.. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost. 2010; 8: 315–23. 10.3402/jev.v2i0.19728.
   PubMed Web of Science ®Google Scholar